The intervention tested is the Medtronic AT500, a device designed to prevent and terminate AT episodes in patients with conventional pacemaker needs. This device is intended to improve patient ...

Medtronic’s pacemaker sales are also expected to gain from the recent positive trial results which are likely to help its new products gain acceptance in the competitive CRDM market.

Medtronic had nearly $2 billion in pacemaker revenues during its 2013 fiscal year. Its 10-year battery life may mean it is not right for ­children, he said. But for adults, ...

The study began in February 2004, with its primary completion and estimated completion dates not specified. The last update was submitted on June 30, 2025. These dates are crucial as they indicate the ...

By removing the leads and having the new pacemaker directly stimulate the heart, Medtronic is making the device safer as well as smaller. At just a fraction of the size of current devices, the new ...

Medtronic said its current pacemakers cost anywhere from $5,000 to $10,000. “The launch of these devices should help offset the recent increase in price erosion in the pacemaker market ...

However, Medtronic‘s dual-chamber leadless pacemaker, named Micra AV2, was approved by the FDA in May, and Boston Scientific is developing a dual-chamber leadless pacemaker as well. presented by ...

business Health Care. FDA warns Medtronic pacemaker patients about potential battery depletion problem A crack can form in an electric component, leading to rapid battery depletion possibly ...

They took their concerns about the discontinued-but-popular pacemaker to Medtronic in late September, after a fourth device among the 448 InSync IIIs implanted at the institute had a power failure.

Medtronic has donated more than 300 pacemakers, including Tara's, to CanPacers, a nonprofit focused on pet cardiology that distributes these pacemakers to veterinary hospitals. Medtronic ...